Validation: Page 4

Immunovia touts performance of PanCan-d test in clinical study
By LabPulse.com staff writers
The test detected pancreatic ductal adenocarcinoma with 99% specificity and 89% sensitivity in stage I/II when excluding individuals with low levels of CA 19-9, an antigen released by pancreatic cancer cells.
February 17, 2022
2019 07 04 00 23 3413 Pancreas New 400
Datar secures FDA breakthrough nod for prostate cancer test
By LabPulse.com staff writers
TriNetra-Prostate identifies early-stage prostate cancer in men between the ages of 55 and 69 with more than 99% accuracy, the company said. It requires 5 ml of blood and is indicated for men with a serum prostate-specific antigen (PSA) measure of 3 ng/mL or higher, according to Datar.
February 13, 2022
2019 04 22 18 53 8505 Lab Blood Liquid Samples 400
AI of pathology slides improves prostate cancer diagnosis
By Joseph Constance
The study suggests that AI has the potential to transform histopathological evaluation and optimize the risk stratification and clinical management of prostate cancer, giving it more of a precision approach, according to the study's authors, from the University of Wisconsin and elsewhere.
November 3, 2021
2021 04 27 15 25 5437 Pathology Digital Workstation Microscope 400
MiR Scientific touts data on prostate cancer liquid biopsy
By LabPulse.com staff writers
MiR Sentinel was able to make the determination from a single urine sample, according to the company. Also, these new data validate a study that was published in September 2020 in the Journal of Urology, the company noted.
September 19, 2021
2021 02 13 00 35 3916 Prostate Cancer 400
FDA clears Thermo Fisher's new blood test for lupus
By LabPulse.com staff writers
The EliA SmDP-S Test is designed to reduce the number of false-positive results and provide improved diagnostic guidance for SLE. The new test enhances specificity without sacrificing sensitivity, Thermo Fisher said.
August 25, 2021
2020 05 07 22 15 9104 Thermo Fisher Scientific 400
Scientists develop spectroscopy-based COVID-19 triage tool
By LabPulse.com staff writers
Indian and Australian researchers collected infrared spectra of blood plasma from 160 COVID-positive patients from Mumbai (130 as a training set for model development and 30 as a blind test set for model validation). They established a simple plasma processing and ATR-FTIR data acquisition procedure using 75% ethanol for viral inactivation.
August 18, 2021
2021 01 15 22 11 6312 Coronavirus Blood Cells 400
AI can lend a hand in diagnosis, prognosis of oral SCC
By Erik L. Ridley
After reviewing published studies in the literature on the use of AI with pathology and radiology images in patients with oral SCC, researchers from the University of Hong Kong concluded that the technology yielded good classification accuracy.
August 18, 2021
2021 08 18 23 12 2135 Computer Ai Artificial Illustration 400
Tempus highlights research results for Tempus xF
By LabPulse.com staff writers
The study, which was published online on July 2 in npj Precision Oncology, found that xF yielded high sensitivity and specificity for calling single-nucleotide variants, insertions/deletions (indels), copy number variants, and gene rearrangement, according to the company.
July 12, 2021
2020 01 16 22 39 3973 Dna Sequencing Genome 400
Third Opinion touts AI disease detection results
By LabPulse.com staff writers
The patented software achieved a median accuracy of 83.8% for classifying 70 types of blood cells and detected 35 out of 70 specific types of blood cells, the company said. It had a 95% accuracy rate in detection of the 35 most common cells for different types of leukemia.
July 1, 2021
2021 04 27 15 25 5437 Pathology Digital Workstation Microscope 400
EarlySign touts study of AI for nonsmall cell lung cancer
By LabPulse.com staff writers
Based on clinical characteristics and laboratory testing performed nine to 12 months before a clinical diagnosis of cancer, the EarlySign model identified lung cancer with a sensitivity of 40.3% and specificity of 95%, according to the company. A positive test result indicated a thirteenfold elevation in the odds of lung cancer.
May 26, 2021
2020 06 01 18 51 2022 Cancer Lung 400
Veracyte to highlight Decipher clinical data at ASCO
By LabPulse.com staff writers
The two studies are the Validation Study on the Impact of Decipher Testing on Treatment Recommendations in African American and Non-African American Men with Prostate Cancer (VANDAAM) and the Swiss Group for Clinical Cancer Research (SAKK) 09/10 trial.
May 24, 2021
2019 06 19 21 28 0345 Prostate 3 D 400
Qiagen, DiaSorin debut Lyme disease assay
By LabPulse.com staff writers
The test has a sensitivity of 74% and a specificity of 100% within 21 days from the first evidence of infection. It is available in markets accepting the CE Mark, and those that use the Liaison analyzer systems.
April 20, 2021
2019 04 19 20 00 0990 Borrelia Burgdorferi Lyme 400
Previous Page
Page 4 of 9
Next Page